These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30334385)

  • 21. Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial.
    Kornowski R; Mehran R; Dangas G; Nikolsky E; Assali A; Claessen BE; Gersh BJ; Wong SC; Witzenbichler B; Guagliumi G; Dudek D; Fahy M; Lansky AJ; Stone GW;
    J Am Coll Cardiol; 2011 Aug; 58(7):704-11. PubMed ID: 21816305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of Different Reperfusion Strategies of Multivessel Disease Undergoing Newer-Generation Drug-Eluting Stent Implantation in Patients with Non-ST-Elevation Myocardial Infarction and Chronic Kidney Disease.
    Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Lee SJ; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    J Clin Med; 2021 Oct; 10(20):. PubMed ID: 34682752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complete revascularization versus culprit-only revascularization in ST-segment elevation myocardial infarction and multivessel disease patients undergoing primary percutaneous coronary intervention: A meta-analysis and trial sequential analysis.
    Wang CH; Zhang SY; Jin XF
    Int J Cardiol; 2017 Feb; 228():844-852. PubMed ID: 27907885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and rationale of the COMPLETE trial: A randomized, comparative effectiveness study of complete versus culprit-only percutaneous coronary intervention to treat multivessel coronary artery disease in patients presenting with ST-segment elevation myocardial infarction.
    Mehta SR; Wood DA; Meeks B; Storey RF; Mehran R; Bainey KR; Nguyen H; Bangdiwala SI; Cairns JA;
    Am Heart J; 2019 Sep; 215():157-166. PubMed ID: 31326681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of the Residual SYNTAX Score on Outcomes of Revascularization in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease.
    Loutfi M; Ayad S; Sobhy M
    Clin Med Insights Cardiol; 2016; 10():29-35. PubMed ID: 26997875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early angio-guided complete revascularization versus culprit vessel PCI followed by ischemia-guided staged PCI in STEMI patients with multivessel disease.
    Meliga E; Fiorina C; Valgimigli M; Belli R; Gagnor A; Sheiban I; Resmini C; Tizzani E; Aranzulla T; Scrocca I; DE Benedictis M; Conte MR
    J Interv Cardiol; 2011 Dec; 24(6):535-41. PubMed ID: 22010970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventive versus culprit-only percutaneous coronary intervention in ST-elevation myocardial infarction patients with multivessel disease: a meta-analysis.
    Song YJ; Shin HC; Yang JI; Lee HY; Jin HY; Seo JS; Yang TH; Kim DK; Kim DS; Jang JS
    J Interv Cardiol; 2015 Feb; 28(1):1-13. PubMed ID: 25689544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-analysis of multivessel coronary artery revascularization versus culprit-only revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease.
    Bangalore S; Kumar S; Poddar KL; Ramasamy S; Rha SW; Faxon DP
    Am J Cardiol; 2011 May; 107(9):1300-10. PubMed ID: 21349487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-eluting versus bare-metal stents in large coronary arteries of patients with ST-segment elevation myocardial infarction: findings from the ICAS registry.
    Abe D; Sato A; Hoshi T; Maruta S; Misaki M; Kakefuda Y; Watabe H; Hiraya D; Sakai S; Kawabe M; Takeyasu N; Aonuma K
    J Cardiol; 2014 Nov; 64(5):377-83. PubMed ID: 24685689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-Staged Compared With Multi-Staged PCI in Multivessel NSTEMI Patients: The SMILE Trial.
    Sardella G; Lucisano L; Garbo R; Pennacchi M; Cavallo E; Stio RE; Calcagno S; Ugo F; Boccuzzi G; Fedele F; Mancone M
    J Am Coll Cardiol; 2016 Jan; 67(3):264-72. PubMed ID: 26796390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Five-year results of the complete versus culprit vessel percutaneous coronary intervention in multivessel disease using drug-eluting stents II (CORRECT II) study: a prospective, randomised controlled trial.
    Fagel ND; van Nooijen FC; Maarse M; Slagboom T; Herrman JP; van der Schaaf RJ; Amoroso G; Patterson MS; Laarman GJ; Suttorp MJ; Vink MA
    Neth Heart J; 2019 Jun; 27(6):310-320. PubMed ID: 30868547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease.
    Hannan EL; Samadashvili Z; Walford G; Holmes DR; Jacobs AK; Stamato NJ; Venditti FJ; Sharma S; King SB
    JACC Cardiovasc Interv; 2010 Jan; 3(1):22-31. PubMed ID: 20129564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Culprit Vessel Versus Multivessel Versus In-Hospital Staged Intervention for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: Stratified Analyses in High-Risk Patient Groups and Anatomic Subsets of Nonculprit Disease.
    Iqbal MB; Nadra IJ; Ding L; Fung A; Aymong E; Chan AW; Hodge S; Della Siega A; Robinson SD;
    JACC Cardiovasc Interv; 2017 Jan; 10(1):11-23. PubMed ID: 28057282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What is the optimal approach to a non- culprit stenosis after ST-elevation myocardial infarction - Conservative therapy or upfront revascularization? An updated meta-analysis of randomized trials.
    Anantha Narayanan M; Reddy YN; Sundaram V; Reddy YN; Baskaran J; Agnihotri K; Badheka A; Patel N; Deshmukh A
    Int J Cardiol; 2016 Aug; 216():18-24. PubMed ID: 27135152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials.
    Sabaté M; Räber L; Heg D; Brugaletta S; Kelbaek H; Cequier A; Ostojic M; Iñiguez A; Tüller D; Serra A; Baumbach A; von Birgelen C; Hernandez-Antolin R; Roffi M; Mainar V; Valgimigli M; Serruys PW; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2014 Jan; 7(1):55-63. PubMed ID: 24332419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multivessel Versus Culprit-only Percutaneous Coronary Intervention in ST-segment Elevation Acute Myocardial Infarction: Analysis of an 8-year Registry.
    Galvão Braga C; Cid-Álvarez AB; Redondo Diéguez A; Trillo-Nouche R; Álvarez Álvarez B; López Otero D; Ocaranza Sánchez R; Gestal Romaní S; González Ferreiro R; González-Juanatey JR
    Rev Esp Cardiol (Engl Ed); 2017 Jun; 70(6):425-432. PubMed ID: 27825718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of complete revascularization in patients with ST-elevation myocardial infarction: analysis of a 10-year all-comers prospective registry.
    Rodrigues G; de Araújo Gonçalves P; Madeira S; Rodrigues R; Borges Santos M; Brito J; Raposo L; Mesquita Gabriel H; Campante Teles R; Almeida M; Mendes M
    Coron Artery Dis; 2016 Mar; 27(2):122-7. PubMed ID: 26689132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meta-Analysis of Culprit-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease.
    Bangalore S; Toklu B; Stone GW
    Am J Cardiol; 2018 Mar; 121(5):529-536. PubMed ID: 29304995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrent Myocardial Infarction After Primary Percutaneous Coronary Intervention in Multivessel Coronary Disease Is Primarily Related to Stent Failure: Post-Hoc Analysis of the PASSION Trial.
    Vink MA; Vos NS; Dirksen MT; Suttorp MJ; Slagboom T; Patterson MS; Kiemeneij F; Laarman G
    J Interv Cardiol; 2015 Dec; 28(6):523-30. PubMed ID: 26643000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Outcomes of Staged Complete Revascularization Versus Culprit Lesion-Only Revascularization for ST-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease.
    Marino M; Crimi G; Leonardi S; Ferlini M; Repetto A; Camporotondo R; Demarchi A; De Pascali I; Falcinella F; Oltrona Visconti L; De Servi S; Ferrario M; De Ferrari GM; Gnecchi M
    Am J Cardiol; 2017 Feb; 119(4):508-514. PubMed ID: 28007297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.